Aquestive Therapeutics, Inc. (AQST)
5.225
+0.12
(+2.25%)
USD |
NASDAQ |
Sep 01, 16:00
5.225
0.00 (0.00%)
After-Hours: 20:00
Aquestive Therapeutics Cash from Operations (TTM) : -45.36M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -45.36M |
| March 31, 2026 | -43.84M |
| December 31, 2025 | -52.43M |
| September 30, 2025 | -50.45M |
| June 30, 2025 | -49.68M |
| March 31, 2025 | -48.78M |
| December 31, 2024 | -35.76M |
| September 30, 2024 | -34.21M |
| June 30, 2024 | -24.68M |
| March 31, 2024 | -25.58M |
| December 31, 2023 | -6.38M |
| September 30, 2023 | 7.008M |
| June 30, 2023 | 12.16M |
| March 31, 2023 | 13.51M |
| December 31, 2022 | -9.789M |
| September 30, 2022 | -26.30M |
| June 30, 2022 | -38.17M |
| March 31, 2022 | -33.36M |
| Date | Value |
|---|---|
| December 31, 2021 | -32.98M |
| September 30, 2021 | -38.43M |
| June 30, 2021 | -37.68M |
| March 31, 2021 | -45.92M |
| December 31, 2020 | -45.46M |
| September 30, 2020 | -42.52M |
| June 30, 2020 | -49.00M |
| March 31, 2020 | -56.17M |
| December 31, 2019 | -60.21M |
| September 30, 2019 | -57.22M |
| June 30, 2019 | -52.37M |
| March 31, 2019 | -36.22M |
| December 31, 2018 | -17.76M |
| September 30, 2018 | -17.59M |
| June 30, 2018 | 7.989M |
| March 31, 2018 | 2.701M |
| December 31, 2017 | 5.824M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| LENZ Therapeutics, Inc. | -113.91M |
| ANI Pharmaceuticals, Inc. | 189.47M |
| Corcept Therapeutics, Inc. | 109.70M |
| Veru, Inc. | -26.04M |
| Johnson & Johnson | 27.61B |